Usage Patterns and Interest in Glucagon-Like Peptide-1 Receptor Agonists for Weight Management: A Population-Based Study in Great Britain - Top-Institutions - MDSpire

Usage Patterns and Interest in Glucagon-Like Peptide-1 Receptor Agonists for Weight Management: A Population-Based Study in Great Britain

  • By

  • Sarah E. Jackson

  • Jamie Brown

  • Clare Llewellyn

  • Oliver Mytton

  • Lion Shahab

  • January 8, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Obesity Medicine
    • Metabolic Research

  • #2

    Joslin Diabetes Center
    Joslin Diabetes Center

    Boston, MA

    Key Differentiators

    • Diabetes Research
    • Endocrinology
    • Obesity Treatment

  • #3

    Imperial College London
    Imperial College London

    London, England

    Key Differentiators

    • Endocrinology
    • Population Health
    • Obesity Research

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Obesity Medicine
    • Clinical Pharmacology

  • #5

    University of Cambridge
    University of Cambridge

    Cambridge, England

    Key Differentiators

    • Endocrinology
    • Metabolic Medicine
    • Population Health

Original Source(s)

Usage Patterns and Interest in Glucagon-Like Peptide-1 Receptor Agonists for Weight Management: A Population-Based Study in Great Britain

  • by Sarah E. Jackson, Jamie Brown, Clare Llewellyn, Oliver Mytton, Lion Shahab

  • January 8, 2026

Related Content

Meta-inflammation in Hidradenitis suppurativa: from pathogenic evidence to therapeutic approaches

Opposing gastric and jejunal regulation of CELA2A in obesity and after Roux-en-Y gastric bypass suggests a role in gastrointestinal metabolic signaling

Impact of beneficiary status on bariatric surgery outcomes in a military treatment facility